Brief: Tempus Announces Multi-Year Collaboration With Moderna And Merck
BRIEF-Tempus Announces Multi-Year Collaboration With Moderna And Merck Oct 7 (Reuters) - Tempus AI, Inc. TEM.O:
TEMPUS ANNOUNCES MULTI-YEAR COLLABORATION WITH MODERNA AND MERCK
TEMPUS - ANNOUNCES EXPANDED MULTI-YEAR COLLABORATION FOR INTISMERAN AUTOGENE COMMERCIALIZATION
TEMPUS - FINANCIAL TERMS OF COLLABORATION NOT DISCLOSED
TEMPUS: TO MANAGE COLLECTION & TRANSFER OF TUMOR TISSUE & BLOOD SAMPLES NEEDED FOR NEXT-GENERATION SEQUENCING
TEMPUS: TO ALSO PROVIDE NGS SERVICES TO SUPPORT INTISMERAN AUTOGENE DESIGN AND MANUFACTURING PROCESS
Source text: ID:nBw1MMdJ5a
Further company coverage: TEM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Merck & Co
See all newsBrief: European Commission Approves Keytruda Plus Padcev As Perioperative Treatment For Adults With Resectable Muscle-Invasive Bladder Cancer
US STOCKS-Dow leads Wall Street higher, investors focus on healthcare stocks
Moderna recoups part of losses as BofA raises PO ahead of key cancer vaccine readout
Live Markets: Dot-com deja vu? Why Goldman Sachs is calling time on the momentum trade
Factbox: Pharma sector doubles down on AI to slash costs, timelines